Delayed
London S.E.
12:40:30 15/05/2024 BST
|
5-day change
|
1st Jan Change
|
7.945
GBX
|
-9.20%
|
|
+27.12%
|
+63.81%
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14.65
|
7.534
|
21.41
|
56.48
|
69.27
|
32.36
|
Enterprise Value (EV)
1 |
4.44
|
0.0222
|
16.66
|
44.68
|
56.39
|
30.34
|
P/E ratio
|
8.51
x
|
-5.02
x
|
-6.46
x
|
182
x
|
63.8
x
|
17.7
x
|
Yield
|
-
|
-
|
4.26%
|
1.61%
|
2.7%
|
3.79%
|
Capitalization / Revenue
|
0.43
x
|
0.1
x
|
0.2
x
|
0.5
x
|
0.54
x
|
0.24
x
|
EV / Revenue
|
0.13
x
|
0
x
|
0.16
x
|
0.39
x
|
0.44
x
|
0.22
x
|
EV / EBITDA
|
-555
x
|
0.04
x
|
7.44
x
|
17.7
x
|
12.8
x
|
6.43
x
|
EV / FCF
|
-
|
-34,068
x
|
2,563,956
x
|
5,900,426
x
|
3,606,204
x
|
-3,129,750
x
|
FCF Yield
|
-
|
-0%
|
0%
|
0%
|
0%
|
-0%
|
Price to Book
|
0.54
x
|
0.29
x
|
0.62
x
|
1.66
x
|
1.96
x
|
0.87
x
|
Nbr of stocks (in thousands)
|
59,795
|
59,795
|
182,186
|
182,193
|
187,229
|
196,097
|
Reference price
2 |
0.2450
|
0.1260
|
0.1175
|
0.3100
|
0.3700
|
0.1650
|
Announcement Date
|
16/08/18
|
15/08/19
|
14/07/20
|
09/08/21
|
10/08/22
|
08/08/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
34.03
|
78.01
|
105.9
|
113.7
|
127.4
|
135.7
|
EBITDA
1 |
-0.008
|
0.631
|
2.238
|
2.52
|
4.417
|
4.718
|
EBIT
1 |
-1.344
|
-1.716
|
-1.086
|
-0.412
|
1.649
|
2.641
|
Operating Margin
|
-3.95%
|
-2.2%
|
-1.03%
|
-0.36%
|
1.29%
|
1.95%
|
Earnings before Tax (EBT)
1 |
1.687
|
-1.815
|
-3.41
|
0.056
|
1.26
|
1.784
|
Net income
1 |
1.438
|
-1.502
|
-2.833
|
0.318
|
1.081
|
1.784
|
Net margin
|
4.22%
|
-1.93%
|
-2.67%
|
0.28%
|
0.85%
|
1.31%
|
EPS
2 |
0.0288
|
-0.0251
|
-0.0182
|
0.001699
|
0.005800
|
0.009299
|
Free Cash Flow
|
-
|
-0.6514
|
6.498
|
7.572
|
15.64
|
-9.694
|
FCF margin
|
-
|
-0.84%
|
6.13%
|
6.66%
|
12.28%
|
-7.14%
|
FCF Conversion (EBITDA)
|
-
|
-
|
290.37%
|
300.48%
|
354.02%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
2,381.17%
|
1,446.54%
|
-
|
Dividend per Share
|
-
|
-
|
0.005000
|
0.005000
|
0.0100
|
0.006250
|
Announcement Date
|
16/08/18
|
15/08/19
|
14/07/20
|
09/08/21
|
10/08/22
|
08/08/23
|
Fiscal Period: March |
2022 S1
|
2022 S2
|
2023 S1
|
---|
Net sales
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
|
1.136
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
EPS
|
0.006200
|
-
|
-
|
Dividend per Share
1 |
-
|
0.005000
|
0.005000
|
Announcement Date
|
15/11/21
|
12/07/22
|
14/11/22
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
10.2
|
7.51
|
4.75
|
11.8
|
12.9
|
2.02
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.65
|
6.5
|
7.57
|
15.6
|
-9.69
|
ROE (net income / shareholders' equity)
|
-
|
-5.64%
|
-9.39%
|
0.93%
|
3.12%
|
4.92%
|
ROA (Net income/ Total Assets)
|
-
|
-2.17%
|
-1.22%
|
-0.39%
|
1.4%
|
2.15%
|
Assets
1 |
-
|
69.1
|
231.9
|
-80.59
|
77.25
|
82.88
|
Book Value Per Share
2 |
0.4600
|
0.4300
|
0.1900
|
0.1900
|
0.1900
|
0.1900
|
Cash Flow per Share
2 |
0.1700
|
0.1300
|
0.0500
|
0.0800
|
0.0800
|
0.0300
|
Capex
1 |
0.15
|
0.27
|
0.4
|
0.78
|
0.42
|
0.73
|
Capex / Sales
|
0.45%
|
0.34%
|
0.37%
|
0.68%
|
0.33%
|
0.54%
|
Announcement Date
|
16/08/18
|
15/08/19
|
14/07/20
|
09/08/21
|
10/08/22
|
08/08/23
|
|
1st Jan change
|
Capi.
|
---|
| +63.81% | 21.64M | | -29.08% | 70.3B | | +2.04% | 27.46B | | -7.08% | 17.8B | | +1.92% | 17.46B | | +0.93% | 15.46B | | +6.78% | 13.49B | | +8.32% | 13.06B | | +68.45% | 12.96B | | +70.12% | 12.56B |
Other Healthcare Facilities & Services
|